Menu
  • Join
  • Login
  • Contact
 

Search abstracts


THE USE OF DIABETES THERAPEUTICS AND PATIENT ADHERENCE IN JAPAN

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: ARIMA, Junko (Japan)
  • Co-author(s): Junko Arima: pharmacy, Kagoshima university hospital, Kagoshima, Japan
    Kazuhiro Inoue: pharmacy, Kagoshima university hospital, Kagoshima, Japan
    Hideki Sugawara: pharmacy, Kagoshima university hospital, Kagoshima, Japan
    Hideyuki Terazono: pharmacy, Kagoshima university hospital, Kagoshima, Japan
    Yasuo Takeda: pharmacy, Kagoshima university hospital, Kagoshima, Japan
  • Abstract:

    Background

    Insulin began to be used in Japan as a treatment for diabetes in the 1920s. Since that time, for about 70 years, biguanides and sulfonylureas have only been used as therapeutic agents. However, in the 2000s, medicines with various action mechanisms such as thiazolidines, glinides and DPP-4 inhibitors were launched, and the range of..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses